Pipeline
ARNAV has several mRNA based products in pre-clinical development.
| Target | Antiviral therapeutics | |||
|---|---|---|---|---|
| Discovery | Pre‑clinical | Phase I | Partner | |
| RSV | ||||
| RSV+ Influenza |
||||
| Vaccine | ||||
| Viral Hemorrhagic Fever | ||||
| Oncology | ||||
| Triple Negative Breast Cancer | ||||